Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

CVS Pharmacy Inc. and the former president of Cigna Corp.'s Express Scripts asked a federal judge to amend an injunction ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

According to the company, effective January 1, 2025, cyclosporine ophthalmic solution 0.1% (Vevye) will be included on key ...

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

KB Brown’s phone hasn’t stopped ringing since Walgreens shut its W. Broadway store last year, leaving one pharmacy to serve 67,000 residents in the north Minneapolis area where he lives and runs his ...

Humana shares drop 7% premarket as Cigna confirms it won't pursue combination with the managed care insurer.

The Cigna Group has a twelve month low of $253.95 and a twelve month high of $370.83. The stock has a market capitalization of $88.96 billion, a P/E ratio of 30.17, a P/E/G ratio of 0.95 and a ...